Stockreport

Structure Therapeutics Reports Third Quarter 2025 Financial Results and Recent Highlights

Structure Therapeutics Inc. - American Depositary Shares  (GPCR) 
PDF Topline 36-week data from oral small molecule GLP-1 receptor agonist aleniglipron ACCESS and ACCESS II studies on track for readouts by year-end 2025 Oral small molecul [Read more]